Emma Beausang
Algemeen Adviseur bij GH RESEARCH PLC
Actieve functies van Emma Beausang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GH RESEARCH PLC | Algemeen Adviseur | - | - |
Loopbaan van Emma Beausang
Eerdere bekende functies van Emma Beausang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Algemeen Adviseur | - | 01-12-2021 |
Opleiding van Emma Beausang
| University of Strathclyde | Undergraduate Degree |
| UCL School of Pharmacy | Doctorate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
| Verenigde Staten | 2 |
| Ierland | 2 |
Operationeel
| General Counsel | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Beurs
- Insiders
- Emma Beausang
- Ervaring
